Figure 2 — Aberrant expression of AKR1B1 indicates poor prognosis and promotes gastric cancer progression by regulating the AKT-mTOR pathway

Research Paper|Volume 15, Issue 18|pp. 9661–9675

Aberrant expression of AKR1B1 indicates poor prognosis and promotes gastric cancer progression by regulating the AKT-mTOR pathway

Back to articleFigure 2(2 of 6)

100%

Figure 2.The overall survival analysis of AKR1B1^pos vs. AKR1B1^neg GC patients in subgroups has been demarcated based on individual clinicopathological indicators.